New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
11:32 EDTHTWR, THORHeartWare falls, Thoratec rallies after Wells Fargo flips ratings
Heart pump maker HeartWare (HTWR) is sinking and its competitor, Thoratec (THOR), is climbing after Wells Fargo wrote that the high rate of strokes among patients who have used Heartware's HVAD pump is worrisome. In a trial of Heartware's HVAD pump, which is designed to draw blood from the left ventricle and propel it through an outflow graft connected to the patient's ascending aorta, 11.8% of patients who used the device developed strokes, versus just 4.3% of patients who used a similar product made by Thoratec, Wells Fargo wrote in a note to investors, citing interim data. As a result, HeartWare has placed a warning about strokes on the instructions for its HVAD pump. Wells Fargo believes that this warning may curtail sales of HeartWare's device in the U.S., and the firm downgraded the company's stock to Market Perform from Outperform in a note to investors today. Wells Fargo also upgraded Thoratec to Outperform from Market Perform, as it expects the company to benefit from reduced demand for HeartWare's solution. Moreover, Wells predicts that HeartWare will report lower than expected 2013 revenue, while Thoratec is likely to beat 2013 revenue expectations. The firm also believes there is now a greater chance that HeartWare's device will not be approved as a destination therapy. In late morning trading, HeartWare fell $4.18, or 4.67%, to $85.36, while Thoratec climbed $1.91, or 5.46%, to $36.91.
News For HTWR;THOR From The Last 14 Days
Check below for free stories on HTWR;THOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
11:41 EDTHTWR, THORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
September 15, 2014
07:21 EDTHTWR, THORHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
16:46 EDTTHORThoratec announces start of Heartmate III U.S. clinical trial
Subscribe for More Information
September 4, 2014
10:01 EDTTHORThoratec management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use